AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) CODEBREAK 200

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of new data from the CodeBreaK clinical trial program, the most comprehensive global...

Related Keywords

United Arab Emirates , Japan , Singapore , Kuwait , Houston , Texas , United States , South Korea , Hong Kong , Switzerland , Saudi Arabia , Russia , Puerto Rico , Argentina , Turkey , Qatar , Tennessee , Taiwan , Australia , Malaysia , Canada , Macao , Macau General , Macau , Brazil , Mexico , United Kingdom , Israel , Chicago , Illinois , Colombia , Thailand , America , Great Britain , American , Celllung Cancerand , Jessica Akopyan , Davids Hong , Stevens Johnson , Michael Strapazon , Melissal Johnson , Spira Al , Youtube , Japan Oncology Group , Sarah Cannon Research Institute At Tennessee Oncology , Docetaxel Across Key Co , Amgen , Teneobio Inc , Kyowa Kirin Co Ltd , World Health Organization , Twitter , European Union , Instagram , Linkedin , Most Sustainable Companies , Chemocentryx Inc , Beigene Ltd , Drug Administration , Therapeutics Inc , Exchange Commission , American Society Of Clinical Oncology , University Of Texas Md Anderson Cancer Center , American Cancer Society , Lung Cancer Research , Demonstrated Delayed Time , Higher Intracranial , Post Hoc Analysis , Docetaxel Across Key Co Alteration Subgroups , Previously Treated , American Society , Clinical Oncology , Annual Meeting , West Japan Oncology Group , Sarah Cannon Research Institute , Lung Cancer , Non Small Cell Metastatic , Consistent Clinical Benefit Across , Investigational Cancer Therapeutics , Cancer Center , Gastrointestinal Cancer , Non Small Celllung Cancerand , Advanced Colorectal Cancer , Safety Information , Lung Disease , Common Adverse Reactions , Dow Jones Industrial Average , Five Prime Therapeutics , Horizon Therapeutics , American Cancer , Lung Cancer Survival , World Health ,